MarketLens

Pricing Plans Sign Up Log in

Stock Analysis Pro

Has Novavax Successfully Pivoted Its Business Model

3 months ago

SHARE THIS ON:

Exclusive Content for Pro Members

Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.

SHARE THIS ON:

Has Innoviva Successfully Pivoted Beyond its Royalty Roots

3 months ago

Is U-Haul's Business Model Resilient Amidst Economic Headwinds

1 months ago

What Makes Main Street Capital's Business Model Unique

3 months ago

What is Marqeta's Core Business Model and How Does It Generate Revenue

1 months ago

Eli Lilly targets vaccines market with $3.8B acquisition of three biotech firms

Eli Lilly and Co. will acquire three vaccine developers—Curevo, LimmaTech Biologics AG, and Vaccine Company—for up to $3.83B. The move marks a strategic expansion into infectious disease prevention, d...

LLY

Stock News•3 weeks ago

Biotech's Next Wave May Already be in Motion

The biotech and pharma sector is entering a pivotal growth phase driven by increased insider conviction, late-stage clinical successes, and emerging platform technologies. These factors are currently ...

NTHI

Stock News•4 weeks ago

Novavax, Inc. (NVAX) Q1 2026 Earnings Call Transcript

Novavax, Inc. (NVAX) released its Q1 2026 earnings transcript, detailing the company's financial performance and operational updates for the period. Investors are reviewing the report to assess the fi...

NVAX

Stock News•1 months ago

Noveris Health Sciences Provides Corporate Update, and Announces Agreement for Acquisition of Stem Cell Distribution Business

Noveris Health Sciences raised CDN $2.3 million in recent financing following a debt restructuring. The company now plans to pivot its primary operations toward commercializing its existing patent por...

STEM